1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Norway >
  5. PharmaLogic Acquires Agilera

M&A Deal Summary

PharmaLogic Acquires Agilera

On April 9, 2025, PharmaLogic acquired life science company Agilera

Acquisition Highlights
  • This is PharmaLogic’s 2nd transaction in the Life Science sector.
  • This is PharmaLogic’s 1st transaction in Norway.

M&A Deal Summary
Date 2025-04-09
Target Agilera
Sector Life Science
Buyer(s) PharmaLogic
Deal Type Add-on Acquisition

Target

Agilera

Kjeller, Norway
Agilera partners with pharmaceutical companies for manufacturing commercial radiopharmaceutical therapies across the United States, Europe, and Asia. The company has three business areas: CDMO, CMO, and Wholesaler and distribution. CDMO: Development partner for innovative radiopharmaceuticals from early phase to clinical production, tailored to customer needs. CMO: Commercial production and distribution. Permits from the Norwegian Medicines Agency and GMP certified. Wholesaler and distribution: Agilera is the national wholesaler of radiopharmaceuticals in Norway. It has a central pharmacy function for radiopharmaceuticals and a logistics centre that distributes radiopharmaceuticals throughout Norway and globally. Agilera is based in Kjeller, Norway.

Search 206,010 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

PharmaLogic

Boca Raton, Florida, United States
Category Company
Founded 1993
Sector Healthcare Services
DESCRIPTION

PharmaLogic operates regional nuclear pharmacies throughout the U.S. which compound and dispense patient-specific intravenous drugs and solutions for use in diagnostic imaging and radiopharmaceutical therapy. PharmaLogic was formed in 1993 and is based in Boca Raton, Florida.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Norway M&A 1 of 1
Year: 2025 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-12-03 Lantheus Puerto Rico Radiopharmacy and PET Manufacturing Facility

San Juan, Puerto Rico

Lantheus' Puerto Rico Radiopharmacy and PET Manufacturing Facility include both the Lantheus radiopharmacy and PMF businesses located in San Juan, Puerto Rico. The radiopharmacy prepares individual, patient-ready doses of radiopharmaceuticals, and the PMF manufactures the drug product for individual, patient-ready doses of fluorodeoxyglucose (FDG).

Buy $18M
Mergr

Product

Company

Legal